Effect of Dapagliflozin on Microvascular and Macrovascular Circulation and Total Body Sodium Content
Status:
Completed
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
Dapagliflozin leads to improved vascular function in the micro- and macrocirculation by
action on various cardiovascular risk factors, in particular by effectively controlling
hyperglycemia, arterial hypertension and reducing whole sodium content amongst others.